←back to thread

275 points swores | 1 comments | | HN request time: 0s | source
Show context
FredPret ◴[] No.40173118[source]
Drugs may be overpriced.

There is probably some bloat in drug development. But then again, maybe not. I'm not an expert.

What I do know is that drugs have gotten dramatically better in the short amount of time I've been alive.

The other thing we all know is that the source of this article, The Guardian and their friends, have a shitlist of industries and institutions it loves to hate.

Ask yourself: will they ever write a positive article about a defense contractor, a bank, big pharma, a US billionaire, or a landlord, even if said entity walks on water and then saves a million babies and the penguins and the world?

replies(4): >>40173169 #>>40173184 #>>40173519 #>>40173529 #
pfdietz ◴[] No.40173169[source]
People who don't like prices of new drugs are free to not use those drugs.

They want to have the benefits of the existence of drugs without paying the cost of discovering the drugs and bringing them to market. It's pernicious entitlement, made more outrageous by complaining about the greed of those actually providing the new drugs.

replies(7): >>40173225 #>>40173317 #>>40173336 #>>40173338 #>>40173448 #>>40173531 #>>40173599 #
AlexandrB ◴[] No.40173317[source]
Ah yes exciting new drugs like insulin[1] and epinephrine[2]. I'm also certain that someone going into anaphylactic shock is extremely well positioned to make a considered decision on whether they like the prices of new drugs like epinephrine or not.

[1] https://www.rand.org/pubs/articles/2021/the-astronomical-pri...

[2] https://www.vox.com/policy/23658275/epipen-cost-price-how-mu...

replies(3): >>40173472 #>>40173903 #>>40174005 #
1. FredPret ◴[] No.40173472{3}[source]
I am of course talking about new drugs. There are lots of really great new ones.

That doesn't mean there aren't shitheads taking advantage of things like insulin etc.

But just because they're also being assholes with regards to insulin et al, doesn't mean that developing new drugs isn't genuinely very expensive, and that those drugs aren't genuinely very good.